SCHEMBL5015310

SCHEMBL5015310

Brc1ccc(-c2cc3cc4nc(cc5ccc(cc6nc(cc2[nH]3)C=C6)[nH]5)C=C4)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.38
▸ STAT1 P42224 1/20 0.38
▸ GCGR P47871 5/20 0.35
▸ MAPK14 Q16539 5/20 0.35
▸ MAPK13 O15264 4/20 0.35
▸ MAPK12 P53778 4/20 0.35
▸ MAPK11 Q15759 4/20 0.35
▸ MAPT P10636 3/20 0.33
▸ MMP2 P08253 2/20 0.33
▸ MMP9 P14780 2/20 0.33
▸ MMP8 P22894 2/20 0.33
▸ MMP13 P45452 2/20 0.33
▸ NR1I3 Q14994 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.32
▸ APP P05067 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ TP53 P04637 1/20 0.31
▸ PTGES O14684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31040338 0.98 STAT3 (0.37) STAT3STAT1GCGRMAPK14MAPK13
SCHEMBL27859875 0.98 STAT3 (0.37) STAT3STAT1GCGRMAPK14MAPK13
SCHEMBL28367025 0.98 STAT3 (0.37) STAT3STAT1GCGRMAPK14MAPK13
SCHEMBL27999723 0.98 STAT3 (0.37) STAT3STAT1GCGRMAPK14MAPK13
SCHEMBL28562984 0.97 STAT3 (0.42) STAT3STAT1GCGRMAPK14MAPK13
Hydrochloric Acid SCHEMBL27999705 0.97 STAT3 (0.36) STAT3STAT1GCGRMAPK14MAPK13
SCHEMBL28999747 0.88 STAT3 (0.38) STAT3STAT1
SCHEMBL3352970 0.85 STAT3 (0.38) STAT3STAT1FGFR1ROCK1AURKB
SCHEMBL29960178 0.85 STAT3 (0.38) STAT3STAT1FGFR1ROCK1AURKB
SCHEMBL8717037 0.85 MEN1 (0.40) STAT3STAT1MAPTMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119454945-A Ultrasonic activated carrier-free nano-drug and preparation method and application thereof 浙江大学 2025-02-18 — — CN claimed
CN-117384094-A Preparation method of alkynyl tetrahydroisoquinoline derivative 江苏中利集团股份有限公司 2024-01-12 — — CN claimed
CN-117164446-A Photocatalytic oxidative degradation method for polymer containing styrene structural unit 大连理工大学 2023-12-05 — — CN claimed
CN-114380839-A Zinc-porphyrin complex and preparation method and application thereof 合肥学院 2022-04-22 — — CN claimed
CN-111693691-A Polymer label based on porphyrin structure 天津华科泰生物技术有限公司 2020-09-22 — — CN claimed
CN-107335458-B A kind of preparation method of nitrogen-doped carbon or iron nitrogen-phosphor codoping carbon electrocatalysis material 华东师范大学 2019-10-01 — — CN claimed
CN-108160094-A A kind of N doping Carbon Materials support noble metal catalyst and preparation and application 中国科学院大连化学物理研究所 2018-06-15 — — CN claimed
CN-102391269-B Zinc protoporphyrin containing heterocyclic ring as well as synthesis and applications of zinc protoporphyrin containing heterocyclic ring and metal complex of zinc protoporphyrin containing heterocyclic ring UNIV NORTHWEST NORMAL 2015-03-18 — — CN claimed
CN-102391269-A Zinc protoporphyrin containing heterocyclic ring as well as synthesis and applications of zinc protoporphyrin containing heterocyclic ring and metal complex of zinc protoporphyrin containing heterocyclic ring UNIV NORTHWEST NORMAL 2012-03-28 — — CN claimed
CN-119454945-A Ultrasonic activated carrier-free nano-drug and preparation method and application thereof 浙江大学 2025-02-18 — — CN disclosed
CN-119039572-A D-A porous organic polymer based on BODIPY and preparation and application thereof 常州大学 2024-11-29 — — CN disclosed
CN-114380839-B Zinc-porphyrin complex and preparation method and application thereof 合肥学院 2024-09-27 — — CN disclosed
CN-117866176-A Porous aromatic framework material and preparation method and application thereof 东北师范大学 2024-04-12 — — CN disclosed
CN-117384094-A Preparation method of alkynyl tetrahydroisoquinoline derivative 江苏中利集团股份有限公司 2024-01-12 — — CN disclosed
CN-105111418-B The preparation method of stereoregular polylactic acid under a kind of temperate condition 武汉理工大学 2016-09-14 — — CN disclosed
US-7417142-B2 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) 2008-08-26 — — US disclosed
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2006-02-09 — — US disclosed
US-6951935-B2 Heteroatom-substituted porphyrins and methods for synthesis of same UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2005-10-04 — — US disclosed
US-20050124596-A1 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2005-06-09 — — US disclosed
US-20030236400-A1 Heteroatom-substituted porphyrins and methods for synthesis of same UNIVERSITY OF TENNESSEE RESEARCH CORPORATION 2003-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes PPOX, HCCS, ICOSLG STAT3 3817/4885STAT1 4312/4885GCGR 4121/4885
US-20030236400-A1 Heteroatom-substituted porphyrins and methods for synthesis of same PPOX, HMBS, UROD STAT3 4156/4885STAT1 3973/4885GCGR 4880/4885
US-20050124596-A1 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same PPOX, PPIF, HMBS STAT3 2986/4885STAT1 3579/4885GCGR 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback